Impact of the 2018 HER2 Testing Focused Update on Classification of dual-probe ISH Groups

被引：0
|
作者：
Schmolze, Daniel [1 ]
Apple, Sophia [2 ]
机构：
[1] City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA
[2] City Hope Natl Med Ctr, Duarte, CA USA
来源：
MODERN PATHOLOGY | 2019年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
249
引用
收藏
页数：1
相关论文
共 50 条
  • [31] HER2 ISH Group 4 Cases: Additional testing and likelihood of identifying a positive result
    Al Dallal, Hiba
    Sanders, Mary Ann
    MODERN PATHOLOGY, 2019, 32
  • [32] HER2 ISH Group 4 Cases: Additional testing and likelihood of identifying a positive result
    Al Dallal, Hiba
    Sanders, Mary Ann
    LABORATORY INVESTIGATION, 2019, 99
  • [33] Impact of the 2018 ASCO/CAP HER2 Guideline Updates on HER2 Assessment in Breast Cancer with HER2 Immunohistochemistry Equivocal Results
    Wen, Hannah
    Ventura, Katia
    Xu, Jin
    Ross, Dara
    Dang, Chau
    Robson, Mark
    Norton, Larry
    Morrow, Monica
    Brogi, Edi
    LABORATORY INVESTIGATION, 2019, 99
  • [34] Impact of the 2018 ASCO/CAP HER2 Guideline Updates on HER2 Assessment in Breast Cancer with HER2 Immunohistochemistry Equivocal Results
    Wen, Hannah
    Ventura, Katia
    Xu, Jin
    Ross, Dara
    Dang, Chau
    Robson, Mark
    Norton, Larry
    Morrow, Monica
    Brogi, Edi
    MODERN PATHOLOGY, 2019, 32
  • [35] HER2 Testing in Gastric and Gastroesophageal Adenocarcinoma-Review and Update
    Koro, Konstantin
    Swanson, Paul E.
    Yeh, Matthew M.
    AJSP-REVIEWS AND REPORTS, 2019, 24 (04) : 179 - 187
  • [36] Genetic heterogeneity of HER2 in breast cancer: impact on HER2 testing and its clinicopathologic significance
    Yang, Yi-ling
    Fan, Yu
    Lang, Rong-gang
    Gu, Feng
    Ren, Mei-Jing
    Zhang, Xin-Min
    Yin, Dong
    Fu, Li
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 134 (03) : 1095 - 1102
  • [37] Update on HER2 testing for breast and upper gastrointestinal tract cancers
    Ross, Jeffrey S.
    BIOMARKERS IN MEDICINE, 2011, 5 (03) : 307 - 318
  • [38] Genetic heterogeneity of HER2 in breast cancer: impact on HER2 testing and its clinicopathologic significance
    Yi-ling Yang
    Yu Fan
    Rong-gang Lang
    Feng Gu
    Mei-Jing Ren
    Xin-Min Zhang
    Dong Yin
    Li Fu
    Breast Cancer Research and Treatment, 2012, 134 : 1095 - 1102
  • [39] Next-Generation Sequencing for HER2 Status in Breast Cancer: Comparison with Immunohistochemistry and in situ Hybridization by 2018 Focused Update
    Mooney, Kelly
    Stehr, Henning
    Kunder, Christian
    Zehnder, James
    Allison, Kimberly
    Lin, Chieh-Yu
    LABORATORY INVESTIGATION, 2019, 99
  • [40] Next-Generation Sequencing for HER2 Status in Breast Cancer: Comparison with Immunohistochemistry and in situ Hybridization by 2018 Focused Update
    Mooney, Kelly
    Stehr, Henning
    Kunder, Christian
    Zehnder, James
    Allison, Kimberly
    Lin, Chieh-Yu
    MODERN PATHOLOGY, 2019, 32
12345